Drug Type Fusion protein |
Synonyms |
Target |
Mechanism CLDN18.2 modulators(Claudin 18.2 modulators), Interleukin-15 receptors modulators(Interleukin-15 receptors modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |